prof. dr. H.M. (Helena) Verkooijen
prof. dr. H.M. (Helena) Verkooijen
- Clinical Trial Office
- Julius Center Research Program Cancer
Research Programs
Biography
Biography
Professor of Evaluation of Image-Guided Treatment, dedicated to improve the life of people with cancer. Committed to full integration of clinical research in routine patient care in order to facilitate undelayed evidence-based implementation of innovations in oncology.
Leader (PI) of several international (H2020) research consortia and academic industrial partnership, head of clinical research office and investigator in a range of (international) scientific studies. Strong background in teaching and development of educational modules at graduate and postgraduate level. Large international academic experience in Europe and Asia. Experienced speaker, moderator, and panel member.
Within the Division of Imaging and Cancer of the UMC Utrecht, I am responsible for clinical evaluation of innovative cancer treatments, and for evaluating to what extent theoretical benefits of these innovations translate into real benefits for patients. I lead a team of post-doc researchers, PhD students, and (medical) graduate students. I also lead the division’s clinical research office, which is responsible for trial support, data management, IT solutions, quality control and medico-ethical advise (supporting 200 academic researchers).
I lead two international consortia (one H2020 European, one transatlantic) and collaborate closely with (international) academic and industry partners. I am regularly invited as speaker at international conferences, educational sessions and consortium meetings, and as panelist at meetings/debates of professional organizations. I serve as a member in several scientific advisory boards and expert committees.
I am Strategic Advisor for 'NTvG Gezonde Zorg', a campaign of the Dutch Journal of Medicine (Nederlands Tijdschrift voor Geneeskunde). This campaign contributes to ensuring sustainability and affordability of health care in the Netherlands by exposing the harms of medicalisation (overdiagnosis and overtreatment) and explicitly demonstrating the power of (primary) prevention.
Side Activities
- Strategic Advisor 'NTvG Gezonde Zorg'
- Board Member Dutch Breast Cancer Research Group (Borstkanker Onderzoek Groep, BOOG)
- Member Scientific Advisory Board Dutch Expert Centre for Screening
- Board Member J.M. Fentener van Vlissingen Fonds
- Member Scientific Advisory Board Dutch Prospective Colorectal Cancer Cohort (PLCRC)
- Member Expert Committee Value-Based Health Care Breast Cancer (NFU)
Research Output (312)
Eijkelboom Anouk H, de Munck Linda, Lobbes Marc B I, van Gils Carla H, Wesseling Jelle, Westenend Pieter J, Guerrero Paez Cristina, Pijnappel Ruud M, Verkooijen Helena M, Broeders Mireille J M, Siesling Sabine, okt 2021, In: Preventive Medicine. 151 , p. 1-10
Batenburg Marilot C. T., Maarse Wies, van der Leij Femke, Baas Inge O., Boonstra Onno, Lansdorp Nina, Doeksen Annemiek, van den Bongard HJGD, Verkooijen Helena M. sep 2021, In: Breast Cancer Research and Treatment. 189 , p. 425-433
Jacobs Daphne H M, Nijmegen Radboud University Medical, Horeweg Nanda, Maduro John H, Speijer Gabrielle, Roeloffzen Ellen M A, Mast Mirjam, Bantema-Joppe Enja, Petoukhova Anna L, van den Bongard Desirée H J G, Koper Peter, Crijns Anne P G, Marijnen Corrie A M, Verkooijen Helena M sep 2021, In: Breast Cancer Research and Treatment. 189 , p. 387-398 12 p.
Hehakaya Charisma, van der Voort van Zyp Jochem, Vanneste Ben, Grutters Janneke, Grobbee Diederick, Verkooijen Lenny, Frederix GW aug 2021, In: Radiotherapy & Oncology. 161 , p. 74-82
Verkooijen Helena M. 30 jul 2021, In: Nederlands Tijdschrift voor Geneeskunde. 165 5 p.
Groen Veerle H., Zuithoff Nicolaas P.A., van Schie Marcel, Monninkhof Evelyn M., Kunze-Busch Martina, de Boer Hans C.J., van der Voort van Zyp Jochem, Pos Floris J., Smeenk Robert Jan, Haustermans Karin, Isebaert Sofie, Draulans Cédric, Depuydt Tom, Verkooijen Helena M., van der Heide Uulke A., Kerkmeijer Linda G.W. 29 jun 2021, In: Radiotherapy and Oncology. 162 , p. 98-104 7 p.
Imran Mahrukh, Kwakkenbos Linda, McCall Stephen J, McCord Kimberly A, Fröbert Ole, Hemkens Lars G, Zwarenstein Merrick, Relton Clare, Rice Danielle B, Langan Sinéad M, Benchimol Eric I, Thabane Lehana, Campbell Marion K, Sampson Margaret, Erlinge David, Verkooijen Helena M, Moher David, Boutron Isabelle, Ravaud Philippe, Nicholl Jon, Uher Rudolf, Sauvé Maureen, Fletcher John, Torgerson David, Gale Chris, Juszczak Edmund, Thombs Brett D 29 apr 2021, In: BMJ Open. 11 18 p.
Kwakkenbos Linda, Imran Mahrukh, McCall Stephen J, McCord Kimberly A, Fröbert Ole, Hemkens Lars G, Zwarenstein Merrick, Relton Clare, Rice Danielle B, Langan Sinéad M, Benchimol Eric I, Thabane Lehana, Campbell Marion K, Sampson Margaret, Erlinge David, Verkooijen Helena M, Moher David, Boutron Isabelle, Ravaud Philippe, Nicholl Jon, Uher Rudolf, Sauvé Maureen, Fletcher John, Torgerson David, Gale Chris, Juszczak Edmund, Thombs Brett D 29 apr 2021, In: BMJ (Clinical research ed.). 373 20 p.
Mink van der Molen Dieuwke R., Bargon Claudia A., Batenburg Marilot C.T., Gal Roxanne, Young-Afat Danny A., van Stam Lilianne E., van Dam Iris E., van der Leij Femke, Baas Inge O., Ernst Miranda F., Maarse Wiesje, Vermulst Nieke, Schoenmaeckers Ernst J.P., van Dalen Thijs, Bijlsma Rhodé M., Doeksen Annemiek, Verkooijen Helena M., apr 2021, In: Breast Cancer Research and Treatment. 186 , p. 577-583 7 p.
Verkooijen Helena M, Henke Lauren E mrt 2021, In: Frontiers in oncology. 11 6 p.